Are Peptides Legal in Brazil? ANVISA Regulations & Research Guide 2026

Brazil's regulatory framework for peptides is governed primarily by ANVISA (Agência Nacional de Vigilância Sanitária), the country's health regulatory authority equivalent to the FDA. As of 2026, most research peptides are not individually classified or scheduled by ANVISA, placing them in a regulatory gray zone similar to many other countries.

This means research peptides such as BPC-157, TB-500, GHK-Cu, and NAD+ can generally be imported for legitimate research purposes. However, peptides that are closely related to approved pharmaceutical products — particularly GLP-1 agonists like semaglutide and tirzepatide — face stricter oversight due to their connection to registered medicines (Ozempic, Mounjaro).

Peptides Pharma supplies all peptide products strictly for research purposes, in full compliance with international export regulations. Brazilian researchers should understand local import requirements before ordering.

ANVISA categorizes substances into several regulatory tiers. Research peptides generally fall outside the lists of controlled substances (Portaria SVS/MS nº 344/1998), which primarily covers psychotropic drugs, narcotics, and specific hormones.

Generally importable for research: - BPC-157 — Not individually listed by ANVISA. Body Protection Compound-157 is a synthetic pentadecapeptide used in tissue repair research. - TB-500 — Thymosin Beta-4 fragment. Used in wound healing and recovery research. Not scheduled. - GHK-Cu — Copper peptide. Widely used in dermatological and anti-aging research. Available in cosmetic products in Brazil. - NAD+ — Nicotinamide Adenine Dinucleotide. Used in longevity and cellular metabolism research. Not controlled. - Glutathione — Antioxidant tripeptide. Available as a supplement in Brazil. - CJC-1295 / Ipamorelin — Growth hormone secretagogues. Used in endocrinology research.

Subject to additional scrutiny: - Semaglutide — Active ingredient in Ozempic/Wegovy. Registered by ANVISA as a prescription medicine. Research-grade material may require additional documentation. - Tirzepatide — Active ingredient in Mounjaro. ANVISA registration pending/recent. Import for research requires clear research justification.

Researchers should document their institutional affiliation and research purpose when importing any peptide into Brazil.

Importing peptides into Brazil involves clearing Receita Federal (Brazilian Federal Revenue Service) customs. Here is what researchers should know:

Documentation recommended: - Invoice with clear product description (research peptide, not pharmaceutical) - Certificate of Analysis (COA) showing purity and composition - Statement of intended research use - Institutional affiliation letter (for university/lab researchers)

Customs process: 1. Package arrives at Brazilian customs (typically Guarulhos or Viracopos for São Paulo) 2. Receita Federal inspects the declaration and may request documentation 3. If flagged, ANVISA may be consulted for classification 4. Once cleared, delivery proceeds to the destination address (typically 7-12 business days total from Europe)

Import duties: Research materials may be subject to standard import tax (Imposto de Importação, typically 60% on goods over USD 50). Institutional importers may qualify for reduced rates under CNPJ institutional import provisions.

Peptides Pharma ships from Europe with full documentation including COA, product descriptions, and customs-friendly packaging to minimize delays.

Brazil is experiencing unprecedented interest in peptide research, driven by several factors:

Semaglutide effect: The massive popularity of Ozempic in Brazil has generated enormous public awareness of peptide-based therapies. Google Trends data for Brazil shows search interest in "peptídeos" and "caneta emagrecedora" (slimming vial) at all-time highs in 2026.

Domestic production: EMS, Brazil's largest pharmaceutical company, invested R$ 1 billion in a peptide manufacturing facility in Hortolândia, São Paulo, with capacity for 20 million vials per year. This signals the scale of anticipated demand.

Academic research: Brazilian universities including USP (Universidade de São Paulo), UNICAMP, UFRJ, and UFRGS have active peptide research programs covering wound healing, metabolic disorders, neurodegeneration, and aging.

Price comparison: Clinical peptide therapies in Brazil cost R$ 1,500–R$ 4,000 per month through pharmacies. Research-grade peptides from international suppliers like Peptides Pharma offer a more accessible option for laboratory and academic research at significantly lower price points.

Growing biohacking community: Brazil's biohacking and longevity community is one of the fastest-growing in Latin America, with active communities in São Paulo, Rio de Janeiro, Curitiba, and Porto Alegre.

Researchers familiar with European regulations should note several key differences in Brazil:

ANVISA vs. EMA/MHRA: - ANVISA tends to be more conservative in approving novel therapeutics but less restrictive on research-grade compound imports - European CE marking and GMP certificates carry weight with Brazilian customs - ANVISA does not maintain a comprehensive list of individual peptides (unlike some EU countries)

Import vs. domestic purchase: - Brazil has limited domestic availability of high-purity research peptides - International import is the primary channel for researchers - Customs clearance adds 1-2 weeks compared to domestic EU delivery

Payment considerations: - PIX is Brazil's most popular instant payment system (used by 150M+ Brazilians) - International purchases can be made via credit card (Visa/Mastercard) or bank transfer - BRL (Real) exchange rates with EUR fluctuate — Peptides Pharma displays prices in BRL for transparency

Documentation culture: - Brazilian institutions typically require nota fiscal (tax invoice) for institutional purchases - Peptides Pharma provides detailed invoices compatible with Brazilian accounting requirements

For researchers looking to purchase peptides for legitimate research in Brazil, follow these steps:

Step 1: Verify your research purpose. Ensure your use case falls within legitimate research applications — academic studies, laboratory testing, institutional research protocols.

Step 2: Choose a reputable supplier. Look for GMP-certified manufacturers, >99% purity verified by third-party COA, and established international shipping to Brazil. Peptides Pharma meets all these criteria.

Step 3: Prepare documentation. Have your institutional affiliation, research purpose statement, and CNPJ (if applicable) ready for customs.

Step 4: Place your order. Peptides Pharma ships to all major Brazilian cities including São Paulo, Rio de Janeiro, Brasília, Belo Horizonte, Curitiba, Porto Alegre, Salvador, Recife, Fortaleza, and Manaus. Delivery takes 7-12 business days.

Step 5: Clear customs. Most orders clear automatically. If Receita Federal requests additional information, your COA and research documentation will expedite the process.

Important: Peptides Pharma sells peptides strictly for research use only. They are not approved by ANVISA for human therapeutic use and must not be marketed or used as medicines in Brazil.